載入中
NASDAQHealthcareMedical - Healthcare Information Services
最新資料
US$0.98
+US$0.0137 · +1.42%
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
前收盤價
US$0.98
+US$0.0137 · +1.42%
盤中時間採用ET。市場資料可能有所延遲。
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
日內區間
目前US$0.98
52週區間
目前US$0.98
盤中時間採用ET。市場資料可能有所延遲。
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
日內區間
目前US$0.98
52週區間
目前US$0.98
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 2.42億 USD | 2.52億 USD | 2.51億 USD | 2.23億 USD | 1.66億 USD |
| 銷貨成本 | 5824.6萬 USD | 5473.3萬 USD | 4748.2萬 USD | 4262.5萬 USD | 4068.9萬 USD |
| 毛利 | 1.83億 USD | 1.97億 USD | 2.04億 USD | 1.8億 USD | 1.25億 USD |
| 研究與開發 | 3477.6萬 USD | 3651.8萬 USD | 4244.1萬 USD | 3489萬 USD | 1856.5萬 USD |
| 銷售、一般及管理費用 | 1.33億 USD | 1.33億 USD | 1.53億 USD | 1.41億 USD | 8925.1萬 USD |
| 營業費用 | 2.04億 USD | 9.08億 USD | 5.34億 USD | 2.24億 USD | 1.53億 USD |
| 利息收入 | 695.1萬 USD | 1459.2萬 USD | 1364.4萬 USD | 278.7萬 USD | 2.9萬 USD |
| 利息支出 | 1128.8萬 USD | 1483.7萬 USD | 1520.3萬 USD | 1120萬 USD | 2590萬 USD |
| 折舊和攤銷 | 5611萬 USD | 5166.7萬 USD | 5175萬 USD | 5690.4萬 USD | 5994.7萬 USD |
| 營業利益 | −2058.3萬 USD | −7.11億 USD | −3.3億 USD | −4404.3萬 USD | −2731.7萬 USD |
| 淨利 | −1.39億 USD | −4.13億 USD | −2.02億 USD | −722.2萬 USD | −5190.8萬 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$1.20
上漲空間 22.45%報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI126.13萬0.00%2.3兆 USD0.03%US$381.94+0.63%
Dimensional - US Small Cap ETFDFAS61.36萬0.00%338.69億 USD0.31%US$78.35+0.32%
Vanguard Extended Market ETFVXF45.38萬0.00%954億 USD0.05%US$235+0.80%
U.S. Micro Cap Portfolio ETFDFMC26.56萬0.00%75.58億 USD0.43%US$57.813+0.20%
Dimensional - US Core Equity 2 ETFDFAC19.74萬0.00%885.96億 USD0.21%US$45.33+0.49%
WisdomTree U.S. SmallCap FundEES11.33萬0.02%6.84億 USD0.38%US$65.48+0.06%
iShares Micro-Cap ETFIWC11.2萬0.01%13.17億 USD0.60%US$183+0.11%
Invesco RAFI US 1500 Small-Mid ETFPRFZ6.98萬0.00%26.7億 USD0.36%US$53.16+0.64%Vanguard Morningstar Total Stock Market ETFVTIDimensional - US Small Cap ETFDFASVanguard Extended Market ETFVXFU.S. Micro Cap Portfolio ETFDFMCDimensional - US Core Equity 2 ETFDFACWisdomTree U.S. SmallCap FundEESiShares Micro-Cap ETFIWCInvesco RAFI US 1500 Small-Mid ETFPRFZAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
